Related Experiment Video
Updated: Jul 16, 2026

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
Published on: September 13, 2022
[What's new in gynecology in 2006?]
P Petignat1, A-T Vlastos, H Bonnefoi
1Service d'obstétrique, Département de gynecologie et d'obstétrique, Maternité, HUG, 1211 Genève.
Abstract:
There were two good news in gynecologic oncology in 2006: intraperitoneal (IP) chemotherapy and the prophylactic vaccines for human papilloma virus (HPV). The ovarian cancer is usually limited to the peritoneal cavity and IP chemotherapy is associated with increased local concentrations. A benefit of this approach on survival was shown in three randomized trials and justifies the recommendation of this treatment for women with a Stage III ovarian cancer, after optimal surgery. Randomized trials have demonstrated the efficacy of two HPV vaccines to prevent a new infection and cytological abnormalities of the cervix. These vaccines will soon be available in Switzerland.
Related Concept Videos
Disorders of the Female Reproductive System
Standards of Care II
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Nursing Assessment of the Genitourinary System II: Inspection and Palpation
